openPR Logo
Press release

Phenylketonuria Market To Register Steady Growth During 2025

01-18-2018 10:50 AM CET | Health & Medicine

Press release from: Transparency Market Research

Phenylketonuria Market To Register Steady Growth During 2025

Phenylketonuria is a genetic disorder, which means it is inherited from one’s parents. In this disease, the patient suffers from a metabolic defect, wherein the body is unable to break down phenylalanine amino acid that is made of protein. Phenylalanine starts accumulating in the blood stream and eventually, it damages the brain. This happens due to mutations in the PAH gene, which result in low levels of the enzyme called phenylalanine hydroxylase. Intellectual impairment, hyperactivity, and mental health disorder are neurological symptoms of phenylketonuria. Skin rashes and order on the skin are physiological symptoms of the disease. If both parents are carriers of PKU, there exists a 25% possibility that their child would be conceived with the confusion; a 50% possibility that the kid would be a transporter; and a 25% possibility that it would neither create nor transport the illness. The fundamental approach to treat PKU is to eat a special diet that cuts off the food containing phenylalanine. Newborn children with PKU can be fed with breast milk. They for the most part likewise need to expend an uncommon recipe known as Lofenalac. At the point of the time when the child has grown enough to eat solid food, giving it a chance to eat foods high in protein needs to be avoided.

Based on type, The Phenylketonuria Market has been segmented into classic PKU, mild PKU, and benign PKU. Moreover, classic PKU is most common type of phenylketonuria, which results in severe brain damage. Based on test, the phenylketonuria market has been divided into diagnostic test and screening test. The screening test segment is expanding at a rapid pace, as the screening test helps detect the disease at its earliest and most treatable stage, especially for the newborn baby. Based on treatment, the phenylketonuria market has been segmented into drug therapy, dietary therapy, gene therapy, and others.

Furthermore, the drug therapy segment has been sub-divided into oral therapy and parenteral therapy. The drug therapy segment is expanding by holding a large market share, as external drugs such as sapropterin dihydrochloride are required to combat the disease. The drug therapy works effectively fulfilling the requirements and maintaining the phenylalanine level in the blood. The market for phenylketonuria in developed economies is witnessing growth, owing to the large number of patients suffering from phenylketonuria, high awareness about the disease, and high diagnostic rate of the disease in these countries. However, issues related to newborn screening is a factor that restricts the phenylketonuria market.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32057

Based on geography, the global phenylketonuria market has been segmented into North America, Europe, Asia Pacific, Latin America, and MEA. The North America phenylketonuria treatment market is expected to hold a high market share during the forecast period, due to the rising number of newborns suffering from phenylketonuria in the region. The rise in awareness among people and improved health care infrastructure in Europe boost the market in the region. The market in Asia Pacific is projected to expand at a significant rate during the forecast period, due to large pool of patients and increase in R&D activities for the development of drugs for phenylketonuria in the region. Moreover, growing economy and availability of newborn screening infrastructure and different screening programs augment the phenylketonuria market in Middle East & Africa.

Some of the key players operating in the global phenylketonuria market are American Gene Technologies International Inc., Dimension Therapeutics, Inc., BioMarin Pharmaceutical Inc., Synthetic Biologics, Inc., Codexis, Inc., SOM Innovation Biotech SL, Daiichi Sankyo Company, Limited, and Erytech Pharma SA.

Pre-Book Full Report -

https://www.transparencymarketresearch.com/checkout.php?rep_id=32057<ype=S

About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Phenylketonuria Market To Register Steady Growth During 2025 here

News-ID: 906663 • Views:

More Releases from Transparency Market Research

Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Study
Tissue Banking Market is Expected to Reach US$ 2,903.3 Million to 2026| TMR Stud …
The global 𝐭𝐢𝐬𝐬𝐮𝐞 𝐛𝐚𝐧𝐤𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 reached a value of US$ 1,056.4 million in 2017 and is projected to nearly triple to US$ 2,903.3 million by 2026, with a robust Compound Annual Growth Rate (CAGR) of approximately 12.0% from 2018 to 2026. Factors such as increasing awareness about tissue donation, technological advancements, and a growing target patient population are anticipated to propel market growth during this period. Moreover, the market is expected
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
Vascular Closure Devices Market to reach US$ 1 Billion by 2027: TMR Study
This report by Transparency Market Research, Inc. assesses the present state and future growth potential of the global 𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐜𝐥𝐨𝐬𝐮𝐫𝐞 𝐝𝐞𝐯𝐢𝐜𝐞𝐬 𝐦𝐚𝐫𝐤𝐞𝐭. It features a comprehensive executive summary, offering insights into various segments of the market. Additionally, the report provides detailed analysis and data on product, access type, application, end user, and regional segments within the global market. Vascular closure devices is estimated to reach a value of ~US$ 1 Bn
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
Digital Health Market Estimated at US$ 1.1 Trillion by 2031, TMR Study
In 2022, the worldwide 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐇𝐞𝐚𝐥𝐭𝐡 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 garnered a valuation of US$ 382.5 billion. Projections indicate a steady growth trajectory, with a compound annual growth rate (CAGR) of 13.1% anticipated from 2023 to 2031, ultimately culminating in a total valuation of US$ 1.1 trillion by the conclusion of 2031. Market analysts foresee a promising outlook characterized by the burgeoning prevalence of chronic diseases and the increasing adoption of smartphones and internet
Global Data Center Networking Market Set to Surge, Forecasted to Reach US$ 56.3 …
The Data Center Networking Market is poised for remarkable growth, driven by the burgeoning demand for cloud-native applications and the rapid adoption of data center virtualization and cloud computing. With an estimated value of US$20.6 billion in 2021, the market is projected to surge at a robust CAGR of 10.8% from 2022 to 2031, reaching a staggering US$56.3 billion by the end of 2031. Get Sample Copy of This Report at:

All 5 Releases


More Releases for PKU

Phenylketonuria (PKU) Market to Witness Robust Expansion by 2025
LP INFORMATION recently released a research report on the Phenylketonuria (PKU) market analysis, which studies the Phenylketonuria (PKU)'s industry coverage, current market competitive status, and market outlook and forecast by 2025. Global “Phenylketonuria (PKU) Market 2020-2025” Research Report categorizes the global Phenylketonuria (PKU) market by key players, product type, applications and regions,etc. The report also covers the latest industry data, key players analysis, market share, growth
Phenylketonuria (PKU) - Pipeline Review, H1 2018
"The Report Phenylketonuria (PKU) - Pipeline Review, H1 2018 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" About Phenylketonuria Market Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Phenylketonuria (PKU) - Pipeline Review, H1 2018, provides an overview of the Phenylketonuria (PKU) (Metabolic Disorders) pipeline landscape. Get Sample copy of this Report @ https://www.marketresearchreports.biz/sample/sample/1509364 Phenylketonuria (also called PKU), is a
Phenylketonuria (PKU) Global Market Key Players – Biomarin, Vitaflo, Mead John …
Summary Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. The global Phenylketonuria (PKU) market will reach xxx Million
Phenylketonuria (PKU) is an inborn error of metabolism
This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioural problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight. The scope
Phenylketonuria (PKU) Market Research Report : 2017
Reports And Markets Publish a New Market Research Report On –"Phenylketonuria (PKU) Market Research Report 2017" Access Full Report With Table Of Contents @ https://www.reportsandmarkets.com/reports/global-phenylketonuria-pku-market-research-report-2017-1541147 In this report, the global Phenylketonuria (PKU) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions,
Phenylketonuria (PKU) - Market Insights, Epidemiology, Outlook to 2025
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Phenylketonuria (PKU)-Market Insights, Epidemiology and Market Forecast-2025” to its report offerings. The report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Phenylketonuria (PKU). Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265871 The report provides an overview of the disease and in depth research related to Phenylketonuria (PKU) for the 7MM (United States,